Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Hypoglycemia

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...

Complications of Diabetes Mellitus

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic Ketoacidosis ll: Pathophysiology

Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Comparative Evaluation of Sputum and Bronchoalveolar Lavage (BAL) Cultures in Clinically Suspected Cases of Community-Acquired Lower Respiratory Tract Infections.

Cureus·2026

Same author

Complicating the Crisis: Superinfection in Covid 19 Patients.

Annals of African medicine·2026

Same author

SARS-CoV-2 altered mitochondrial DNA methylation in Indian COVID-19 patients.

Scientific reports·2026

Same author

Serine recombinases are conserved genetic markers of antiphage defense systems.

bioRxiv : the preprint server for biology·2025

Same author

COVID and depression among stratified population groups: a narrative review.

European journal of medical research·2023

Same author

Flow cytometry profiling of cellular immune response in COVID-19 infected, recovered and vaccinated individuals.

Immunobiology·2023

Search research articles

Related Experiment Video

Updated: May 25, 2026

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Published on: July 5, 2024

Silent myocardial infarction during hypoglycemic coma.

Varun Vijay Mahajan¹, Vikas Dogra, Iesha Pargal

¹Department of Medicine, Gian Sagar Medical College, Ramnagar, District Patiala, India.

Indian Journal of Endocrinology and Metabolism

|January 26, 2012

Summary

This summary is machine-generated.

Hypoglycemia, a common diabetes complication, can lead to neurological issues like seizures and coma. It also increases the risk of heart problems, including myocardial infarction, necessitating routine ECGs for diabetic patients.

Keywords:

Diabetes mellitus hypoglycemia silent myocardial infarction

More Related Videos

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Published on: June 11, 2020

Related Experiment Videos

Last Updated: May 25, 2026

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Cerebral Ischemic Coma Model Induced by Modified Four-Vessel Occlusion

Published on: July 5, 2024

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

A Mouse Model of Hemorrhagic Transformation Induced by Acute Hyperglycemia Combined with Transient Focal Ischemia

Published on: November 15, 2024

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Continuous Video Electroencephalogram during Hypoxia-Ischemia in Neonatal Mice

Published on: June 11, 2020

Area of Science:

Endocrinology
Cardiology
Neurology

Background:

Diabetes mellitus treatment frequently results in hypoglycemia.
Neurological complications such as seizures and coma are recognized risks of hypoglycemia.
Hypoglycemia is an emerging risk factor for cardiovascular complications in diabetic individuals.

Observation:

Myocardial ischemia and infarction are documented occurrences during hypoglycemic episodes.
A potential association exists between hypoglycemia and cardiovascular events in diabetic patients.

Findings:

Hypoglycemic episodes in diabetic patients are linked to an increased risk of cardiovascular complications.
Myocardial ischemia and infarction can manifest during hypoglycemia.

Implications:

Diabetic patients experiencing hypoglycemia should undergo routine electrocardiogram (ECG) monitoring.
Early detection and management of hypoglycemia-induced cardiac events are crucial.
Integrating cardiac risk assessment into diabetes care is recommended.